Charlotte's Web Holdings, Inc. (CWBHF)
OTCMKTS
· Delayed Price · Currency is USD
0.0967
-0.0037 (-3.68%)
May 15, 2025, 11:35 AM EDT
Charlotte's Web Holdings Revenue
Charlotte's Web Holdings had revenue of $12.26M in the quarter ending March 31, 2025, with 1.14% growth. This brings the company's revenue in the last twelve months to $49.81M, down -14.53% year-over-year. In the year 2024, Charlotte's Web Holdings had annual revenue of $49.67M, down -21.36%.
Revenue (ttm)
49.81M
Revenue Growth
-14.53%
P/S Ratio
0.32
Revenue / Employee
444.69K
Employees
112
Market Cap
15.90M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Charlotte's Web Holdings News
- 1 day ago - Charlotte's Web Reports Year-Over-Year Growth For Q1 2025 - PRNewsWire
- 2 months ago - Charlotte's Web Holdings Inc. (CWBHF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Charlotte's Web Reports 2024 Fourth Quarter and Year-End Financial Results - PRNewsWire
- 2 months ago - Charlotte's Web 2024 Fourth Quarter Earnings Call and Webcast Notice - PRNewsWire
- 2 months ago - Charlotte's Web Announces DeFloria to enter Phase 2 FDA Clinical Trial for Autism Spectrum Disorder Treatment - PRNewsWire
- 2 months ago - DeFloria Receives Investigational New Drug Application Clearance from FDA for Phase 2 Clinical Trial of AJA001, an Oral Cannabinoid Drug Being Developed for the Treatment of Autism Spectrum Disorder (ASD) - PRNewsWire
- 5 months ago - Charlotte's Web Provides Update on DeFloria's Phase 1 Results Targeting Autism Spectrum Disorder - PRNewsWire
- 5 months ago - DeFloria Announces Positive Results from Phase 1 Trial of AJA001 Being Developed for the Treatment of Autism Spectrum Disorder (ASD) - PRNewsWire